In the published article, there were two errors in Figures 4, 5. First, the unit of four concentrations in Figures 4A,B were mismarked as “mg/mL.” The correct unit should be “μg/mL” in the quantization map of Figures 4A,B. Second, the wrong images were used in Figures 5A,B (at the concentration of 25 μg/mL). The corrected Figures 4, 5 and their captions appear below.
FIGURE 4
FIGURE 5
The authors apologize for these errors and states that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
Terminalia catappa, melanoma, antimetastasis, matrix metalloproteinases-2, Wnt/ βcatenin pathways
Citation
Chang C-K, Chu S-C, Huang J-Y, Chen P-N and Hsieh Y-S (2022) Corrigendum: Terminalia catappa leaf extracts inhibited metastasis of A2058 and A375 melanoma cells via downregulating p-Src and β-catenin pathway in vitro. Front. Pharmacol. 13:1074693. doi: 10.3389/fphar.2022.1074693
Received
19 October 2022
Accepted
07 November 2022
Published
18 November 2022
Volume
13 - 2022
Edited and reviewed by
Chien-shan Cheng, Shanghai Jiao Tong University, China
Updates
Copyright
© 2022 Chang, Chu, Huang, Chen and Hsieh.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pei-Ni Chen, peini@csmu.edu.tw; Yih-Shou Hsieh, csmcsh@csmu.edu.tw
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.